Gotion High-tech unveils new products and new technology, charge up to 80% in just 9.8 minutes
May 20, 2024 00:33 ET
|
Gotion High-Tech Co., Ltd.
HEFEI, China, May 20, 2024 (GLOBE NEWSWIRE) -- Gotion High-tech hosted its 13th Technology Conference on May 17, unveiling its new products and new technology, including 5C ultra-fast charging...
Hepsor U34 SIA, Hepsor AS group company, signed construction agreement for the construction of StokOfiss 34 project in Riga
May 20, 2024 00:00 ET
|
HEPSOR AS
Hepsor U34 SIA, a subsidiary of Hepsor AS Group, and construction company Mitt&Perlebach signed a contract on May 17, 2024, for the construction of a development project called StokOfiss 34 in...
Christie’s International Real Estate Enters Vietnam, One of the Fastest-Growing Luxury Markets in the World, via Partnership with S&S Group
May 19, 2024 22:00 ET
|
Christie's International Real Estate
CHICAGO and HO CHI MINH CITY, Vietnam, May 19, 2024 (GLOBE NEWSWIRE) -- In recent years, Vietnam has emerged as one of the fastest-growing luxury real estate markets in the world, home to a growing...
万利能源国际有限公司与嘉吉国际公司携手支持塔塔钢铁的运载航程
May 19, 2024 21:00 ET
|
CBL International Limited
香港, May 20, 2024 (GLOBE NEWSWIRE) -- 万利集团（以下简称「集团」）（美国纳斯达克交易所代码：BANL）子公司，亚太地区知名的船舶燃油供应公司，万利能源国际有限公司（「万利能源」）有幸参与印度塔塔钢铁集团（「塔塔钢铁」）从新西兰格拉德斯通到印度巴拉迪普的运载航程，该航程已于5月8日圆满完成。...
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
May 19, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymeworks Inc. (NASDAQ:...
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
May 19, 2024 20:53 ET
|
Virios Therapeutics
ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
May 19, 2024 20:00 ET
|
Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Organic Pigments Market worth $6.0 billion by 2029 Globally, at a CAGR of 6.5% says MarketsandMarkets™
May 19, 2024 19:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 19, 2024 (GLOBE NEWSWIRE) -- The Global Organic Pigments Market is estimated at USD 4.4 billion in 2024 and is projected to reach USD 6.0 billion by 2029, at a CAGR of 6.5% from 2024 to...
Qifu Technology Announces First Quarter 2024 Unaudited Financial Results
May 19, 2024 18:00 ET
|
Qifu Technology, Inc.
SHANGHAI, China, May 19, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its...
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
May 19, 2024 18:00 ET
|
bioLytical Laboratories Inc.
bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)
- May 19, 2024 09:30 ET DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UnitedHealth
- May 19, 2024 05:14 ET The 12th China (Hunan) International Mineral & Gem Expo Opens